Chapter 16: The Gastrointestinal Tract

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to this deep dive.

Today, we're taking your clinical biochemistry notes, specifically the incredibly complex world of the gastrointestinal tract, and we're just extracting the absolute highest yield insights.

Right.

So whether you are staring down a major college exam or you're just trying to make sense of metabolic medicine, we are going to connect the dots between the raw physiology, the lab tests, and actual patient care.

I think that is the perfect way to frame it.

Okay.

Because to really understand gastrointestinal disorders,

you first have to master the normal physiological baseline.

We'll start with how your body handles normal digestion and absorption and the highly specific local hormones that control all of it.

Once you have that solid foundation, the pathophysiology just makes perfect sense.

Totally.

And that logical flow will lead us straight into how specific laboratory tests uncover exactly where the system broke down.

And finally, how you can apply those findings to manage a patient.

Okay.

Let's unpack this starting right at the baseline.

I actually want to talk about fluid dynamics first because the sheer volume the gut handles is honestly, it's genuinely mind blowing.

It really is.

Your GI tract processes an astonishing eight to nine liters of fluid every single day.

And the wild part is most of that isn't even what you drink.

It's derived from your own endogenous secretions.

So saliva, gastric juices, bile.

Right.

And that massive volume is actually crucial because digestion requires food to be highly diluted to work properly.

But your gut is incredibly efficient.

It reabsorbs about 98 % of that fluid, mostly in the small intestine.

You end up losing only about 100 to 200 milliliters daily in the stool.

Which is incredible efficiency.

Exactly.

So we trace that digestive journey.

It starts right in the mouth.

Mastication mixes food with saliva, which contains the enzyme alpha amylase that immediately starts breaking down complex carbohydrates.

And then the food hits the stomach.

Yes.

Here, highly acidic fluid is added.

That drops the pH significantly and initiates protein digestion via the enzyme pepsin.

But the stomach also secretes something called intrinsic factor, right?

Which it doesn't digest anything locally, but it becomes super important later on.

Correct.

Intrinsic factor is a glycoprotein that is absolutely essential for vitamin B12 absorption further down the line.

We will definitely come back to that.

Okay.

Finally, the acidic contents move into the duodenum.

Here, alkaline fluid and pancreatic enzymes are added to neutralize the acid.

And they digest proteins into amino acids,

polysaccharides into simple sugars, and fats into fatty acids.

So the stomach is adding this highly acidic fluid to the mix, but how does it know when to turn the faucets on?

Like it can't just be pumping acid all the time.

It isn't.

It relies on a very tight three -part trigger system.

First is the vagus nerve, which responds directly to the cerebral cortex.

This is literally the sight, smell, and taste of food triggering your stomach to prep.

Oh, wow.

Interestingly,

the vagus nerve also responds to hypoglycemia.

So clinically, triggering low blood sugar with insulin can actually be used to test if a surgical vagotomy was complete.

If the acid doesn't rise when blood sugar drops, the nerve was successfully cut.

That's a clever test.

Second, we have gastrin, which is a hormone carried by the bloodstream to the stomach's parietal cells to stimulate acid.

Gastrin secretion is stimulated by calcium, which explains why patients with chronic hypercalcina often suffer from peptic ulcers.

Ah, that makes sense.

And it's inhibited by the acid itself in a classic negative feedback loop.

And the third trigger ties into pharmacology, doesn't it?

Histamine.

It does.

Histamine binds to specific cell surface receptors to stimulate acid production.

But there are two distinct types of receptors here.

H1 receptors are found on smooth muscle cells, and those are targeted by your standard allergy

Right, like what you take for hay fever.

Exactly.

However, H2 receptors are found directly on the gastric parietal cells.

Standard antihistamines have no effect on them.

Instead, drugs known as H2 blockers, like ranitidine, they compete with histamines specifically at these H2 receptors to reduce stomach acid.

Got it.

You also have proton pump inhibitors, like omeprazole, which bypass the receptors entirely to shut down the acid pumping enzyme right at the source.

Knowing that normal baseline makes the pathophysiology so much clearer.

Take gastric hypersecretion.

In the very rare Zalinger -Ellison syndrome, a patient develops a gastronoma, usually a tumor localized in the pancreas or duodenum.

Right.

This tumor just pumps out massive unregulated amounts of gastrin, leading to severe acid hypersecretion in chronic ulcers.

Contrast that with hyposecretion, which we see in pernicious anemia.

Yeah, in pernicious anemia, the body forms autoantibodies that literally destroy its own gastric parietal cells.

Wow.

Since those cells produce both the acid and the intrinsic factor we mentioned earlier, the patient ends up with almost no stomach acid and more dangerously an inability to absorb vitamin B12 later on.

We also have to consider structural changes, right?

Like what happens after a surgical gastrectomy.

Without a normal stomach acting as a reservoir, patients can develop post -gastrectomy syndromes.

Exactly.

The early dumping syndrome happens soon after a meal.

Because the stomach can't hold the food, a hypertonic fluid mixture rushes rapidly into the duodenum.

Just floods it.

Yes.

And to dilute this massive osmotic load, water is pulled directly from the extracellular space straight into the gut lumen.

This sudden drop in blood plasma volume causes the patient to feel faint, and the massive fluid shift causes severe abdominal discomfort.

Then you have the late dumping syndrome, which is basically a massive delayed sugar crash.

A high glucose meal rapidly enters the duodenum without being paced by the stomach.

Right.

The glucose is absorbed incredibly fast, causing a huge spike in blood sugar.

The body panics and releases a massive surge of insulin to handle it.

But about two hours later, that insulin overswing causes severe reactive hypoglycemia.

That perfectly transitions us further down the track to intestinal absorption.

Anatomy plays a huge role here.

The absorptive surface area of the small intestine is enormous.

It isn't just a smooth pipe.

No, it has macroscopic folds, which are covered in tiny finger -like projections called villi, which are in turn covered in microscopic microvilli.

This architecture just increases the absorptive area exponentially.

And navigating this vast folded landscape are the gut peptides, the local hormones that control motility and secretions.

We already mentioned gastrin stimulating stomach acid.

Right.

Then there is called the cystokinin, or CCK, which triggers the gallbladder to contract and the pancreas to release its digestive enzymes.

Secretin stimulates the pancreas to release bicarbonate -rich alkaline fluid to neutralize the incoming stomach acid.

And interestingly, pancreatic polypeptide does the exact opposite, right?

It inhibits pancreatic secretion.

Exactly.

And finally, vasoactive intestinal polypeptide, VIP, and mobilin, which regulate the physical motility of the gut.

With those local hormones orchestrating the environment, we can look at how specific macronutrients are absorbed, starting with carbohydrates.

Complex polysaccharides are broken down into desaccharides by amylase and then into monosaccharides by brush border enzymes like lactase and sucrase.

Right.

But clinically, if a patient is malnourished, how do we test if this absorptive surface is actually working?

We use the xylose absorption test.

Yes.

I've seen the xylose absorption test mentioned a lot when differentiating between pancreatic issues and intestinal issues.

Why use xylose specifically?

What makes it such a clever diagnostic tool?

It is brilliant because of its simplicity.

Xylose is a pentose sugar that does not need to be digested by pancreatic enzymes to be absorbed.

And its metabolism isn't affected by insulin.

Okay.

Because it passes freely through the kidneys glomeruli, most of whatever is absorbed ends up in the urine.

So if a patient drinks xylose and excretes normal amounts in their urine, we know their intestinal mucosa is excitably absorbing it.

And if excretion is low, the intestinal surface itself is damaged.

Exactly.

And because pancreatic enzymes aren't required, a patient with a completely destroyed pancreas will still have a normal xylose test.

It cleanly differentiates between the two.

So how is the test actually run?

The details of the protocol really matter here.

The patient fasts overnight.

At 8 .08 .00 hours, they empty their bladder, discard that urine, and drink a five -gram dose of xylose dissolved in water.

Just five grams.

We specifically use a five -gram dose rather than a larger 25 -gram dose because too much xylose acts osmotically and will just cause diarrhea, totally ruining the test.

So all urine passed between 08 .00 and 10 .00 goes into a designated bottle one.

At 10 .00, they empty their bladder into bottle one.

Then all urine between 10 .0000 goes into bottle two.

At 13 .00, they empty their bladder into bottle two, and the test is complete.

A normal subject should excrete more than 1 .5 grams of xylose over those combined five hours.

But there is a huge trap to watch out for with this test, isn't there?

Regarding the kidneys.

A massive trap.

The biggest source of error is impaired renal function.

If the kidneys aren't filtering properly, the xylose is absorbed by but it stays in the blood instead of passing into the urine.

So it looks like a gut problem, but it's not.

Right.

This gives a falsely low urine result, making it look like an intestinal problem when it's actually a kidney problem.

This is incredibly common in the elderly, so you should never run a xylose test if glomerular function is even slightly impaired.

And moving from carbs to protein absorption.

Dietary proteins are initially tackered by gastric pepsin in the stomach, but the heavy lifting is done in the duodenum by pancreatic enzymes like trypsin.

But trypsin is secreted in an inactive form, right?

Trypsinogen.

Yes, if the pancreas secreted active trypsin, it would digest its own tissue.

Which would be bad.

Very bad.

It secretes inactive trypsinogen, which travels to the gut.

Right on the intestinal brush border, an enzyme called enterocinase waits to activate the trypsinogen into trypsin, kicking off protein digestion exactly where it is supposed to happen.

Okay, let's look at lipids.

Fat digestion seems like an incredibly complex multi -step masterpiece.

Because dietary triglycerides are completely insoluble in water, they first need to be emulsified.

This is done by bile salts, which are synthesized in the liver, stored in the gallbladder, and secreted into the bile.

They recirculate constantly via the enterohepatic circulation.

Right.

Once emulsified, pancreatic lipase swoops in to hydrolyze the triglycerides.

Eh.

But lipase needs help.

It requires a vital coenzyme called colipase.

Okay, what does colipase do?

Colipase anchors the lipase directly at the fat water interface, prevents the bile salts from inhibiting the enzyme, and drops its optimal pH to 6 .5, which perfectly matches the duodenal lumen.

So, to visualize this, the bile salts act almost like dish soap breaking apart a greasy pan into smaller droplets.

Yes.

And then the colipase anchors the actual digestive enzymes to those tiny fat droplets so they can do their work.

That is a brilliant analogy.

The resulting fatty acids then clump together with bile salts and fat soluble vitamins to form tiny, negatively charged structures called micelles.

Micelles, right.

These micelles are up to a thousand times smaller than the original emulsion droplets, allowing them to slip right through the microvilla spaces into the enterocytes.

Inside the intestinal cells, they are repackaged into colomocrons and sent into the lymphatic system.

And to test if this fat absorption process is failing, we look for statorrhea excess fat in the stool.

The traditional fecal fat estimation test requires a strict three -day stool collection because a single 24 -hour collection is just too inaccurate due to variable transit times.

Exactly.

A mean excretion of more than 18 millimoles, or five grams per day, indicates statorrhea.

There is also the tri -align breath test, where the patient consumes a 14C labeled triglyceride.

We then measure the ratio of carbon dioxide in their expired breath.

If the ratio is low, they aren't absorbing and metabolizing the fat.

We also need to quickly cover vitamins and minerals.

We mentioned vitamin B12 requires that intrinsic factor for the stomach, but it is specifically absorbed way down in the terminal ilium.

Oh, right.

Calcium and magnesium absorption require vitamin D, meaning if you aren't absorbing fats because vitamin D is fat soluble, you aren't absorbing calcium either.

And iron is absorbed in its Fe2 plus ferrous form, primarily in the duodenum and upper jejunum.

All of this relies heavily on normal pancreatic function.

The exocrine pancreas secretes both the alkaline fluid to neutralize stomach acid and the digestive enzymes themselves.

To test pancreatic exocrine function in the lab, we often look at plasma enzymes.

Amylase is common.

It rises significantly in acute pancreatitis, but it has flaws, doesn't it?

It does.

Amylase is nonspecific and clears very quickly in the urine.

Furthermore, severe lipemia, extremely high blood triglycerides can actually interfere with the assay, causing a spurious normal or low amylase level even during an acute attack.

Wow, that's dangerous.

It is.

Lipase is much more specific for the pancreas and has a longer half -life, making it better for late diagnosis.

We also test trypsin, which is uniquely used as a newborn screening test for cystic fibrosis.

How does that work?

Well, in a newborn with CF, the blocked ductuals cause pancreatic enzymes to back up into the blood, leading to high plasma trypsin in the first few weeks of life.

We also have tubeless tests to check pancreatic function without inserting invasive tubes into the duodenum.

There's the PAYBA test.

What exactly is PAYBA?

PAYBA stands for parametobenzoic acid.

In this test, the patient swallows a synthetic peptide attached to PAYBA.

If the pancreas is producing enough chymotrypsin, that enzyme will snip the bond, releasing the PAYBA to be absorbed into the blood and urinated out.

That's really elegant.

Right.

If there's no PAYBA in the urine, the pancreas isn't doing its job.

There's a similar protocol called the pancreal oral test and also FACAL elastase screening, which is a fantastic simple stool test where low elastase indicates severe pancreatic exocrine insufficiency.

So to see how this plays out in the real world, let's imagine a 57 -year -old patient rushing into the ER.

His blood pressure is crashing and he's clutching his upper abdomen in severe pain.

His labs are striking.

Amylase is massively elevated at 2 ,567 units per liter.

Very high.

His glucose is high at 17 .5 millimoles per liter, and his calcium is alarmingly low at 1 .89 millimoles per liter.

This is a classic presentation of acute pancreatitis, likely caused by gallstones blocking the pancreatic duct.

The pathophysiology explains his lab numbers perfectly.

Break that down for us.

Sure.

The severe necrosis disrupts the endocrine pancreas, specifically the islets of Langerhans, halting insulin production and causing the hyperglycemia.

Meanwhile, the systemic inflammation and the saponification of fats, where fat necrosis basically turns abdominal fat into soap by binding circulating calcium, leads to his severe hypocalchemia.

Clinicians actually use a specific scoring system, right?

Ransom or Glasgow criteria to gauge how deadly an attack like this might be.

Yes.

They look at factors at presentation and during the first 48 hours, like an age over 55, a white blood cell count over 16, glucose over 10, or massive fluid sequestration of more than six liters.

If a patient hits more than seven criteria, the mortality rate nears 100%.

It's extremely serious.

It's also worth noting that pancreatic carcinoma often presents very late, sometimes with painless obstructive jaundice, and is monitored using the tumor marker CA19 -99.

Now let's contrast our two main types of malabsorption syndromes.

Intestinal absorptive failure versus pancreatic digestive failure.

Okay.

In intestinal disease, you frequently see a dimorphic anemia, which is a mixed megaloblastic and iron deficiency anemia because the damaged surface can't absorb iron or folate.

In cancreatic disease, anemia is rare.

And what about the tests we talked about?

The Xylus test will be reduced in intestinal disease, but normal in pancreatic.

Conversely, the Pebe test and Fakily elastase will be normal in intestinal disease, but markedly abnormal in pancreatic disease.

A classic intestinal cause is villous atrophy.

Imagine a 31 -year -old woman presenting with a 15 -kilogram weight loss, chronic diarrhea, and a hemoglobin of 8 .9 due to folate deficiency.

Her plasma tissue transglutaminase, or TTG antibodies, are strongly positive.

Coeliac disease.

Exactly.

Coeliac disease, caused by a severe sensitivity to the protein alpha -glyadin found in gluten.

The immune response causes the intestinal delay to literally flatten out, destroying the absorptive surface.

But there is a massive clinical caveat here regarding IgA deficiency, right?

This is a vital trap to avoid.

Coeliac screening often relies on IgA anti -TTG antibodies.

However, IgA deficiency is surprisingly common in Coeliac patients.

So if you only test their IgA antibodies and they are genetically IgA deficient, you will get a false negative and miss the diagnosis entirely.

If a patient is IgA deficient, you must use IgG anti -TTG antibodies instead.

That's a huge point to remember.

Other conditions reduce the surface area too, like tropical sprue or shortcut syndrome, which is defined as a patient having less than 200 centimeters of viable small bowel remaining after surgery.

But malabsorption can also stem from impaired enzyme activity.

Consider a 32 -year -old woman with known cystic fibrosis.

She presents with diabetes, a low potassium of 2 .8 millimoles per liter, and an unbelievable faecal fat excretion of 65 millimoles per day.

This highlights the systemic nature of cystic fibrosis.

CF involves mutation, most commonly, a three -base pair deletion in codon 508 of the gene.

This single missing phenylalanine amino acid leads to a misfolded CFTR protein.

The cell recognizes it's misfolded and destroys it before it ever reaches the cell membrane.

Without those chloride channels, secretions become incredibly thick and viscous.

In the pancreas, these concrete like secretions completely block the ducts.

The pancreatic enzymes physically cannot reach the So she has profound exocrine failure, causing the massive 65 millimoles of faecal fat.

That explains the fat.

What about the diabetes?

Over time, the backed up enzymes destroy the entire gland, leading to endocrine failure and causing her diabetes.

The hypokalemia is simply due to chronic potassium loss from prolonged diarrhea.

Moving to more specific malabsorption issues, there is blind loop syndrome.

This happens when anatomical pouches or surgically created blind loops cause intestinal contents to stagnate.

Bacteria proliferate wildly in these stagnant pools and literally consume the patient's vitamin B12 before it can reach the terminal ileum, causing megaloblastic anemia.

We diagnose this abnormal bacterial growth using breath tests, specifically the 13C or 14C xylose breath test or the 14C glycotulate test, where the overgrown bacteria act on the isotope and we measure the labeled carbon dioxide in the expired air.

Another specific issue is secaridase deficiency, primarily lactase deficiency.

Acquired lactase deficiency is very common worldwide, though there is an extremely rare congenital form.

Because the lactase enzyme on the brush border is missing.

Yes, lactose from dairy isn't absorbed, it stays in the gut lumen, acts osmotically to draw in water, and the colonic bacteria ferment it into gas and acids.

We diagnose this with a hydrogen breath test.

You just drink lactose, right?

Exactly.

The patient drinks a lactose solution, and if they can't digest it, the colonic flora rapidly ferment it, resulting in elevated hydrogen gas measured in their breath.

We also occasionally see protein losing enteropathy, where the intestinal wall becomes abnormally permeable, leaking massive amounts of protein directly into the gut.

We can diagnose this by measuring alpha -1 antitrypsin, a protein resistant to degradation directly in the stool.

We really need to connect the dots on the metabolic consequences of all this malabsorption.

If you can't absorb fat, you lose your fat -soluble vitamins.

Lack of vitamin A causes night blindness.

Lack of vitamin D halts calcium absorption, causing osteomalacia or tetany.

Vitamin E deficiency causes severe neurological symptoms.

Vitamin K deficiency leads to bleeding problems.

Plus, the failure to absorb protein leads to severe hypoalbuminemia, dropping the oncotic pressure of the blood and causing widespread edema.

We can systematize this diagnostic logic cleanly.

If a patient presents with steaturia, your first step is to run a tubeless pancreatic test like PEBA or fecal elastase.

If that test is normal, the pancreas is fine, so you move to the xylose test.

If the xylose test is abnormal, it points directly to upper small intestine disease, and you confirm that with a mucosal biopsy.

And if they just have watery diarrhea, you need to know if it's osmotic or secretory.

You do this by calculating the osmotic gap of the fecal fluid using a specific formula, two times the sum of the sodium plus the potassium concentrations.

If the measured osmolality of the stool is significantly greater than that calculation, there is an unmeasured osmotically active substance present, like unabsorbed lactose or a hidden laxative.

Let's apply this logic to one final clinical scenario.

We have a 60 -year -old woman with a history of severe alcohol abuse and multiple past attacks of acute pancreatitis.

She presents with profound weakness, pale, foul -smelling stools, and peristhesiae tingling and spasms in her hands.

Her labs show a fasting glucose of 17, albumin at 28, and calcium extremely low at 1 .8.

If we connect this to the bigger picture,

the multiple acute attacks over the years have completely destroyed her pancreas, leading to chronic pancreatitis.

She now has complete endocrine failure, hence the diabetic glucose of 17 requiring insulin.

She has complete exocrine failure, causing the steatorrhea and protein malabsorption, which explains her low albumin of 28.

Because she cannot absorb fat, she cannot absorb vitamin D, which means she cannot absorb calcium.

And that hypocalkymia is what's causing the neurological peristhesia, known as tetany.

Yes.

To manage her care, she needs insulin, high -dose calcium and vitamin D supplements, and an oral pancreatic enzyme extract, like Creon, taking with every meal.

That perfectly ties the physiology, labs, and clinical care together.

Now the source material also covers gut tumors and abdominal pain.

You always have to consider other pathologies.

Is the patient secretly abusing purgatives or laxatives?

Are they infected with H.

pylori, which we can detect with a urea breath test?

Do they have inflammatory bowel disease, marked by elevated fecal calprotectin?

Or could it be colorectal cancer, which we screen for using fecal occult blood tests?

And then there are the incredibly rare but clinically fascinating gut hormone tumors of the enteropancreatic system.

We've already mentioned gastronomas causing Solinger -Ellison syndrome, where fasting gastron levels skyrocket above 1 ,000 micrograms per liter, and an intravenous secretin test paradoxically causes the gastron to rise even higher.

But there are also glucagonomas, which arise from the alpha cells of the pancreas.

These present with a very unique listering skin rash called necrolitic migratory erythema, alongside new onset diabetes and weight loss.

Such a distinct presentation.

And my personal favorite, VIPOMAS.

These tumors secrete massive amounts of vasoactive intestinal polypeptide, causing Berner -Morrison syndrome.

The clinical triad here is unforgettable.

Massive watery diarrhea, severe hypokalemia from the fluid loss,

and aclohygia, a complete lack of stomach acid.

Finally, we must remember that an acute abdomen, severe sudden abdominal pain, isn't always surgical.

There are rapid -fire biochemical causes to rule out.

Diabetic ketoacidosis, or DKA,

causes severe metabolic acidosis that can mimic peritoneal irritation.

Severe hyperkalemia can cause smooth muscle spasms in the gut.

An adisonian crisis from sudden adrenal failure causes severe electrolyte shifts that mimic abdominal shock.

Acute porphyria causes intense, poorly localized neuropathic pain in the abdomen.

An ectopic pregnancy must always be ruled out via a beta -HCG pregnancy test.

And even heavy metal toxicity, like lead poisoning, can cause severe intestinal colic and spasms.

You must look beyond the surgical science.

That is a lot to consider.

It is.

I'd like to leave you with a final thought to mull over as you study.

Throughout this session, we've treated the GI tract primarily as a functional pipe for digestion and absorption, but the physiology hints at something far more profound.

With phenomena like VIPOMAS and carcinoid syndrome, we see that local gut hormones have the power to completely hijack the body's cardiovascular and nervous systems.

What new diagnostic doors might open when we stop viewing the gut merely as a site of absorption,

and start treating it as the body's largest, most volatile endocrine gland?

That is a brilliant perspective to keep in mind.

We hope this deep dive has helped you connect those physiological pathways directly to the lab results and patient care, giving you a serious edge.

You've got this.

Thank you for studying with the Last Minute Lecture Team.